Aphria Inc.

Most Recent

  • Tilray logo over marijuana harvest
    Cannabis

    Is Tilray (TLRY) Stock a Good Buy? According to Jefferies, Yes

    By Rachel Curry
  • Marijuana plant
    Cannabis

    What the Tilray and Aphria Merger Means for Investors

    By Mohit Oberoi, CFA
  • Cannabis plant with OrganiGram and Aphria logos
    Cannabis

    Aphria or OrganiGram? Which is a Better Stock for Investors?

    By Adam Goodpasture
  • Person holding marijuana leaf
    Cannabis

    Tilray and Aphria Merger Date Nears, Don’t Ignore the Arbitrage

    By Mohit Oberoi, CFA
  • Worker at a cannabis farm
    Cannabis

    Why Investors Should Choose APHA Over TLRY Before the Merger

    By Mohit Oberoi, CFA
  • should i buy aphria stock
    Financials

    Aphria Stock Looks Solid Long Term, Cannabis Sector Heats Up

    By Ruchi Gupta
  • uploads///AdobeStock_
    Company & Industry Overviews

    Top Developments in the Cannabis Industry’s Early Years

    In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

    By Adam Jones
  • uploads///weed _
    Company & Industry Overviews

    Cannabis Products: Tilray Partners with AB InBev

    On December 19, Tilray (TLRY) announced a “research partnership” with one of the largest alcoholic beverage companies—AB InBev.

    By Adam Jones
  • uploads///herb _
    Miscellaneous

    What Citron Research Has to Say about Aphria

    Last week was a brutal week for Aphria (APHA) (APHQF).

    By Adam Jones
  • uploads///seedling _
    Miscellaneous

    Eight Capital Cut Aphria’s Target Price

    Aphria stock lost nearly 25% on December 5. The stock has lost 42% in the three trading days in December.

    By Adam Jones
  • uploads///International strategy
    Company & Industry Overviews

    Law Firms Investigate Aphria for Potential Violations

    Due to Aphria’s (APHA) (APHQF) broad sell-off, several investors lost their investments. The investments might not be recovered.

    By Adam Jones
  • uploads///cannabis _
    Company & Industry Overviews

    Aphria Continued to Fall despite the Company’s Defense

    On December 4, Aphria issued a press release defending its acquisitions in Latin America. The company tried to boost investors’ confidence.

    By Adam Jones
  • uploads///weed _
    Company & Industry Overviews

    Why Did Aphria Stock Fall 30% in November?

    Aphria (APHQF) stock declined nearly 30.6% in November. The stock closed at 10.5 Canadian dollars on November 30.

    By Adam Jones
  • uploads///foliage _
    Company & Industry Overviews

    Aurora Advances in Czech Republic with Medical Cannabis Shipments

    On November 27, Aurora Cannabis (ACB) (ACBFF) announced that it completed its first shipment to the Czech Republic.

    By Adam Jones
  • uploads///seedling _
    Company & Industry Overviews

    Canopy Growth Completes EBBU Acquisition

    Canopy Growth (WEED) (CGC) announced yesterday that it completed the previously announced acquisition of EBBU.

    By Adam Jones
  • uploads///Earnings Loss Per Share Estimates
    Earnings Report

    Most Cannabis Companies Expected to Report Losses for the Quarter

    Aurora Cannabis is estimated to report a loss per share of 0.07 Canadian dollars, which would be lower than the profit per share of 0.01 Canadian dollars in the corresponding quarter in 2017.

    By Adam Jones
  • uploads///herb hemp plant cab cannabinoid
    Company & Industry Overviews

    Why Canopy Growth Partnered with The Brink’s Company

    On November 8, Canopy Growth (CGC) (WEED) announced a multiyear partnership with The Brink’s Company (BCO).

    By Adam Jones
  • uploads///Implied Demand
    Company & Industry Overviews

    Jeff Sessions’ Resignation Could Be Good News for Cannabis Stocks

    On November 7, US Attorney General Jeff Sessions resigned from his position.

    By Adam Jones
  • uploads///weed _
    Company & Industry Overviews

    October Was Tough on Cannabis Stocks: What’s Ahead?

    The Horizons Marijuana Life Sciences ETF (HMMJ) lost almost 24% in October alone, and the ETFMG Alternative Harvest ETF (MJ) also fell ~24%.

    By Adam Jones
  • uploads///Forward EV to EBITDA Multiple for Cannabis Sector
    Company & Industry Overviews

    Analyzing the Cannabis Sector’s EV-to-EBITDA Multiple

    The median EV-to-EBITDA multiple of the nine cannabis stocks as of October 23 stood at 34x, which declined from 44.6x as of October 9.

    By Adam Jones
  • uploads///cannabis _
    Company & Industry Overviews

    Canopy Growth Is Optimistic about Cannabis Market

    Recreational cannabis sales began in Canada on October 17. Canada is only the second country after Uruguay to legalize cannabis.

    By Adam Jones
  • uploads///Aphria and Altria Stock
    Company & Industry Overviews

    Tobacco Companies and Their Newfound Interest in Cannabis

    On October 10, Reuters reported that tobacco giant Altria is in discussions with Aphria (APHQF) about acquiring a stake in the company.

    By Adam Jones
  • uploads///CGC Brands
    Company & Industry Overviews

    Canopy Growth Exporting Medical Cannabis for US Research

    On October 9, Canopy Growth (CGC) (WEED) announced that it has completed a legal transfer of medical cannabis to the United States.

    By Adam Jones
  • uploads///SQDC
    Company & Industry Overviews

    Cannabis Company Namaste Caught in Yet Another Controversy

    On October 9, Namaste, a licensed cannabis producer in Canada, was caught in the middle of yet another controversy related to litigation against the company.

    By Adam Jones
  • uploads///hemp leaf _
    Company & Industry Overviews

    Aurora Cannabis Moves Closer to Uruguay and Colombia

    Aurora Cannabis has moved closer to having a presence in Uruguay and Colombia. The company’s board approved the deal with ICC Labs.

    By Adam Jones
  • uploads///Aphria
    Company & Industry Overviews

    Aphria Announces Developments in South American Markets

    On September 27, Aphria (APHQF) announced developments in the South American market with the acquisition of LATAM Holdings.

    By Adam Jones
  • uploads///Aphria Analysts NTM Recommendation and Target
    Miscellaneous

    A Look at Aphria’s Price Target in September

    The overall consensus recommendation for Aphria is a “buy.”

    By Adam Jones
  • uploads///Canopy Growth Analysts NTM Recommendations and Targets
    Miscellaneous

    Analysts Raise Price Target for Canopy Growth in September

    Canopy Growth is one of the top cannabis stocks (MJ) in terms of market capitalization followed by Aurora Cannabis (ACB) (ACBFF) and Aphria (APHQF).

    By Adam Jones
  • uploads///Product mix
    Company & Industry Overviews

    How Cannabis Companies Are Blanketing the Cannabis Market

    Product differentiation appears to be the primary strategic direction for most cannabis players to blanket the market with several products.

    By Adam Jones
  • uploads///Tilray Kilograms Sold and Averaege Price
    Earnings Report

    Tilray’s Q2 2018 Results and Its Strategic Focus

    Tilray’s (TLRY) average selling prices and sales volume improved YoY in the second quarter. The company sold 1,514 kilograms during the quarter.

    By Adam Jones
  • uploads///Hydropothecary Analysts NTM Recommendation and Target
    Miscellaneous

    How Analysts Rate Hydropothecary in August

    Hydropothecary (HYYDF) has done much better than other cannabis producers (HMMJ) such as Cronos (CRON), Aphria (APHQF), and Aurora Cannabis (ACB) (ACBFF).

    By Adam Jones
  • uploads///weed _
    Earnings Report

    Aphria Reports Quarterly Loss, PI Financial Raises Price Target

    Aphria (APH) (APHQF) reported its fiscal 4Q 2018 earnings on August 1. It more than doubled its sales but had a net quarterly loss.

    By Adam Jones
  • uploads///EBITDA and EBITDA Margin
    Basic Materials

    SMG’s Margin Expectations Could Be Concerning

    The Scotts Miracle-Gro Company (SMG) continues to face margin headwinds in the lawn and garden segment.

    By Adam Jones
  • uploads///northern lights _
    Company & Industry Overviews

    Aurora Cannabis Announces Partnership with Cosmetic Company

    On July 11, Aurora Cannabis announced it had established an agreement with Evio Beauty Group to develop hemp-based and CBD-based cosmetic products.

    By Adam Jones
  • uploads///Forward EV to EBITDA Multiple for Cannabis Sector
    Company & Industry Overviews

    What EV-to-EBITDA Multiples Say about the Cannabis Sector

    The EV-to-EBITDA multiple for the cannabis sector increased slightly to 36.3x as of July 10 from 35.4x a month ago.

    By Adam Jones
  • uploads///Forward EV to Sales Multiple for Cannabis Producers
    Company & Industry Overviews

    Which Cannabis Stocks Are above Peer Median Valuation Multiple?

    As of July 10, Canopy Growth (WEED) (CGC) was trading at a forward enterprise-value-to-sales multiple of 23.7x.

    By Adam Jones
  • uploads///cannabis _
    Company & Industry Overviews

    How Cannabis Stocks Fared Last Week

    The Horizons Marijuana Life Sciences ETF rose 1.7% between June 29 and July 6.

    By Adam Jones
  • uploads///Tobacco Use in Canada
    Company & Industry Overviews

    Why Product Landscape Design Matters for Cannabis Stocks

    The popularity of various cannabis consumption methods could guide the product landscape design for cannabis companies.

    By Adam Jones
  • uploads///Aphria Analysts NTM Recommendation and Target
    Miscellaneous

    Aphria Stock: Analyst Recommendations and Target Prices

    As of July 4, the average consensus price target for Aphria stood at 23.91 Canadian dollars.

    By Adam Jones
  • uploads///plant _
    Company & Industry Overviews

    Why the Cannabis Sector Rallied Last Week

    Last week’s impressive gains pushed some of the cannabis stocks into positive YTD returns territory.

    By Adam Jones
  • uploads///Forward EV to EBITDA Multiple for Cannabis Sector
    Company & Industry Overviews

    What Investors Are Paying for Cannabis Sector’s Forward EBITDA

    The enterprise-value-to-EBITDA multiple for Canadian-licensed producers moved sideways in the last two weeks.

    By Adam Jones
  • uploads///marijuana _
    Company & Industry Overviews

    Cannabis Sector Update for the Week Ended May 4

    Last week was broadly positive for the cannabis sector. The ETF Horizons Marijuana Life Sciences (HMMJ) rose 2.4%.

    By Adam Jones
  • uploads///Chart Title
    Company & Industry Overviews

    The Cannabis Sector: Mergers, Acquisitions, and Price Upgrades

    The cannabis sector remains hot for mergers and acquisitions as companies rush to capture a piece of the recreational cannabis market.

    By Adam Jones
  • uploads///hemp _
    Company & Industry Overviews

    Cannabis Sector Closes Positively in the Week Ended April 13

    Last week (ended April 13), overall market sentiment was positive, with the S&P 500 rising 2% and the TSX 30 gaining 44 basis points.

    By Adam Jones
  • uploads///MedReleaf Analysts NTM Recommendations and Targets
    Miscellaneous

    What Analysts Recommend for MedReleaf

    As of March 22, the consensus analyst mean rating on MedReleaf was 1.6, which remained unchanged from the previous month.

    By Adam Jones
  • uploads///Aphria Analysts NTM Recommendation and Target
    Miscellaneous

    March Analyst Ratings and Price Targets for Aphria

    Aphria (APHQF) was among the worst performers this year with a loss of 34% YTD (year-to-date).

    By Adam Jones
  • uploads///Aphria Average Cost Per Gram
    Company & Industry Overviews

    Digging into Aphria’s Cost of Production

    In this part of the series, we’ll discuss how Aphria’s (APHQF) production costs have evolved in the last four quarters.

    By Adam Jones
  • uploads///Canopy Growth Stock on March
    Company & Industry Overviews

    Why Alcaliber Makes Sense for Canopy Growth

    On March 6, Bloomberg Markets reported that Canopy Growth (WEED) put in a bid for privately held Spanish company Alcaliber.

    By Adam Jones
  • uploads///Med Releaf
    Company & Industry Overviews

    How MedReleaf’s Capacity Expansion Plans Compare to Its Peers’

    MedReleaf (MEDFF) has all of its facilities and expansion projects based in Ontario, Canada (HMMJ).

    By Adam Jones
  • uploads///Aurora Cannabis
    Company & Industry Overviews

    Unlike Canopy, Aurora Cannabis Will Build Capacity outside Canada

    Aurora Cannabis (ACB) (ACBFF), another licensed cannabis producer, is also doing its part to expand its capacity.

    By Adam Jones
  • uploads///Factors of decision
    Company & Industry Overviews

    Factors Expected to Influence the Provinces’ Supplier Decisions

    Ahead of the legalization of recreational cannabis, companies are ramping up their production capacities.

    By Adam Jones
  • uploads///marijuana _
    Company & Industry Overviews

    How Cannabis Companies Are Rushing to Expand Operations

    In anticipation of recreational cannabis’s legalization at the federal level in Canada, provinces have been doing their best to prepare.

    By Adam Jones
  • uploads///Revenue Estimate Revisions for
    Miscellaneous

    Analysts’ Revenue Estimate Revisions for Cannabis Stocks in March

    Cannabis producers’ (HMLSF) sales are expected to rise on expectations of their capturing the recreational cannabis market.

    By Adam Jones
  • uploads///CMED Acquisition
    Company & Industry Overviews

    Shoppers Drug Mart Makes Supply Deal with Aurora Cannabis

    Last week, Shoppers Drug Mart entered a supply agreement with Aurora Cannabis (ACB)(ACBFF) for medical cannabis.

    By Adam Jones
  • uploads///mmj _
    Company & Industry Overviews

    Why Cannabis Stock Cronos Group Surged 11% Yesterday

    On February 26, cannabis company (HMMJ) Cronos Group (MJN)(PRMCF) surged almost 10.8%.

    By Adam Jones
  • uploads///Provider
    Company & Industry Overviews

    Manitoba and Quebec Announced Cannabis Retailers and Suppliers

    Last week, the province of Manitoba announced four private consortiums and companies to retail marijuana in the province.

    By Adam Jones
  • uploads///Top Holdings
    Company & Industry Overviews

    A Look at 2 New Marijuana ETFs that Debuted Last Week

    While marijuana stocks (MJX) ended in the negative territory week-over-week last week, two new marijuana sector-specific ETFs debuted.

    By Adam Jones
  • uploads///marijuana _
    Company & Industry Overviews

    Key Developments in the Cannabis Sector Last Week

    The week ending February 16 wasn’t so positive for marijuana stocks even though the broader market indexes ended in the positive territory.

    By Adam Jones
  • uploads///Gross Margins
    Earnings Report

    How Canopy Growth’s Margins Looked in 3Q18

    During 3Q18, Canopy Growth reported a non-GAAP (generally accepted accounting principles) gross margin of 58% of sales.

    By Adam Jones
  • uploads///Kilograms Harvested and Sold
    Earnings Report

    What Were Canopy Growth’s 3Q18 Sales Drivers?

    Sales volume, mix, and selling prices are key drivers for Canopy Growth’s (WEED) sales as well as for companies (HMLSF) such as Aphria (APHQF), Aurora Cannabis (ACBFF), and MedReleaf (MEDFF).

    By Adam Jones
  • uploads///EBITDA Margin FY  Estimates
    Company & Industry Overviews

    What Analysts Estimate for Cannabis Companies’ Earnings Margins

    Let’s now look at how capacity expansion could translate into cannabis companies’ margins.

    By Adam Jones
  • uploads///MedReleaf Analysts NTM Recommendation and Target
    Basic Materials

    MedReleaf’s Analyst Ratings and Price Target

    The current consensus mean rating for MedReleaf stood at 1.6 with an overall “buy” recommendation on the stock for the next-12-month period.

    By Adam Jones
  • uploads///Aurora Cannabis Analysts NTM Recommendation and Target
    Consumer

    Aurora Cannabis’s Price Target and Analyst Ratings

    The current consensus mean price target on Aphria stood at 9.00 Canadian dollars, which is significantly below the company’s price of 11.50 Canadian dollars on February 6.

    By Adam Jones
  • uploads///Sales Channel
    Miscellaneous

    Aurora Cannabis: Does Investment in Liquor Stores Fit Framework?

    With the opportunity for private players to run cannabis stores in British Columbia and Alberta, the partnership of Aurora Cannabis and Liquor Stores NA could come at an opportune time.

    By Adam Jones
  • uploads///Store Locations
    Miscellaneous

    Aurora Cannabis Announced Another Investment on February 5

    On February 5, 2018, Aurora Cannabis (ACB) (ACBFF) issued a press release that gave details on its latest investment in Liquor Stores NA (LIQ).

    By Adam Jones
  • uploads///Next  Year Sales Revision
    Miscellaneous

    How Analysts’ Estimates for Cannabis Companies Have Evolved

    Earlier, we were left with the question of whether the valuations of cannabis stocks had been stretched. To answer that question, we’ll have to look at what was priced in to their valuation multiples.

    By Adam Jones
  • uploads///TSX Index Sectors Daily Change as on February
    Tech & Comm Services

    Why Cannabis Stocks Fell in the Week Ended February 2

    The week ended February 2, 2018, was negative not only for cannabis stocks but also for the broader market.

    By Adam Jones
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.